当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析 - 现金流量表

安科生物

(300009)

  

流通市值:124.61亿  总市值:170.60亿
流通股本:12.22亿   总股本:16.73亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,942,518,539.311,260,699,934.56583,728,044.362,452,332,687.93
  收到其他与经营活动有关的现金20,924,369.7318,024,534.839,454,540.0352,883,663.02
  经营活动现金流入小计1,963,442,909.041,278,724,469.39593,182,584.392,505,216,350.95
  购买商品、接受劳务支付的现金253,992,435.56167,714,074.274,002,187.9244,164,943.72
  支付给职工以及为职工支付的现金396,052,356.08279,157,334.19105,926,634.65606,093,180.3
  支付的各项税费182,425,373.5140,098,177.151,874,478.18223,785,041.13
  支付其他与经营活动有关的现金575,134,446.28375,330,049.59166,150,306.76745,801,238.71
  经营活动现金流出小计1,407,604,611.42962,299,635.08397,953,607.491,819,844,403.86
  经营活动产生的现金流量净额555,838,297.62316,424,834.31195,228,976.9685,371,947.09
二、投资活动产生的现金流量:
  收回投资收到的现金998,815,662.41967,304,820.53976,416,335.241,222,631,500
  取得投资收益收到的现金14,942,163.6412,040,010.456,645,145.9933,712,137.85
  处置固定资产、无形资产和其他长期资产收回的现金净额441,709.56385,905.68245,490.05894,578.08
  处置子公司及其他营业单位收到的现金净额-1,924,052.250--
  收到的其他与投资活动有关的现金3,187,300.962,380,232.05919,845.284,985,499.52
  投资活动现金流入小计1,015,462,784.32982,110,968.71984,226,816.561,262,223,715.45
  购建固定资产、无形资产和其他长期资产支付的现金54,382,690.7132,753,045.6321,265,986.47117,223,979.91
  投资支付的现金1,172,426,545.09768,905,236.21987,008,702.941,314,047,731.94
  取得子公司及其他营业单位支付的现金---1,199,616.67
  投资活动现金流出小计1,226,809,235.8801,658,281.841,008,274,689.411,432,471,328.52
  投资活动产生的现金流量净额-211,346,451.48180,452,686.87-24,047,872.85-170,247,613.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,000,000---
  其中:子公司吸收少数股东投资收到的现金3,000,000---
  取得借款收到的现金7,000,0007,000,000-5,000,000
  收到其他与筹资活动有关的现金23,991,248.2811,313,750--
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计33,991,248.2818,313,750-5,000,000
  偿还债务支付的现金5,000,0005,000,000--
  分配股利、利润或偿付利息支付的现金418,080,540.88418,065,411.16165,333,622.2418,044,713.66
  其中:子公司支付给少数股东的股利、利润4,680,4604,680,460-2,471,820
  支付其他与筹资活动有关的现金63,807,982.7960,355,491.7541,207,094.3762,335,037.07
  筹资活动现金流出小计486,888,523.67483,420,902.91206,540,716.57480,379,750.73
  筹资活动产生的现金流量净额-452,897,275.39-465,107,152.91-206,540,716.57-475,379,750.73
四、汇率变动对现金及现金等价物的影响-3,069,341.75-2,908,775.77-2,470,049.3376,401.94
五、现金及现金等价物净增加额-111,474,77128,861,592.5-37,829,661.8539,820,985.23
  加:期初现金及现金等价物余额298,604,934.97298,604,934.97298,604,934.97258,783,949.74
  期末现金及现金等价物余额187,130,163.97327,466,527.47260,775,273.12298,604,934.97
补充资料:
  净利润-374,553,615.38-715,837,906.16
  资产减值准备-3,099,669.73-16,815,268.43
  固定资产和投资性房地产折旧-39,476,338.06-77,450,675.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-39,476,338.06-77,450,675.17
  无形资产摊销-17,147,117.78-9,292,031.96
  长期待摊费用摊销-1,643,528.22-3,057,288.71
  处置固定资产、无形资产和其他长期资产的损失--520,388.61--1,089,285.1
  固定资产报废损失-133,968.03-149,021.93
  公允价值变动损失-986,558.98--10,518,654.06
  财务费用-2,272,731.63--2,657,230.34
  投资损失--11,188,455.65--15,525,438.76
  递延所得税--2,849,632.47--17,183,579.56
  其中:递延所得税资产减少--2,234,525.8--15,229,440.73
    递延所得税负债增加--615,106.67--1,954,138.83
  存货的减少-9,883,159.38--69,931,515.29
  经营性应收项目的减少--295,679,594.77--20,453,213.95
  经营性应付项目的增加-160,568,867.1--69,589,297.06
  其他-11,318,637.72-35,366,329.25
  现金的期末余额-327,466,527.47-298,604,934.97
  减:现金的期初余额-298,604,934.97-258,783,949.74
  现金及现金等价物的净增加额-28,861,592.5-39,820,985.23
公告日期2025-10-282025-08-222025-04-292025-03-28
审计意见(境内)标准无保留意见
TOP↑